KRAS and neoplasm: In contrast to the above, RNA-sequencing and tumor microenvironment analysis studies have found that inhibiting ER signaling promotes a pro-tumor microenvironment in Kras mutant tumors, with evidence for estrogen in STAT3 signaling [158].